To a Sustainable Quality Policy

Quality Improvement Clinical Trial

Official title:

The Implementation and Impact of a Rapid-cycle Quality Indicator Feedback Mechanism on Patients and Professionals: a Case Study of Sint-Trudo Hospital

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT04200209
• Other study ID #: SQP4ST
• Status: Enrolling by invitation
• Phase: N/A
• Start date: August 15, 2020
• Est. completion date: June 1, 2026

Study information

• Verified date: February 2024
• Source: KU Leuven
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators need stronger feedback loops and a quality monitoring and management system to improve the quality of care in sustainable way. The Chair Sint-Trudo "To a sustainable quality policy" was established to scientifically develop prerequisites for a sustainable quality of care. In this study protocol, a monocentric mixed-method quasi-experimental study will be used to assess the impact of a rapid-cycle quality indicator feedback mechanism on both patients and professionals.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 400
• Est. completion date: June 1, 2026
• Est. primary completion date: January 1, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients admitted in the hospital for more than one night

Exclusion Criteria:

• Patients admitted in the hospital for less than one night

Related Conditions & MeSH terms

• Management Systems
• Public Health
• Quality Improvement

Intervention

Other:
• Implementation of a quality indicator feedback mechanism
Audit and feedback: A summary of clinical performance and hospital safety culture over a specified period of time. Benchmarking Achievable: benchmarks are calculated from the performance of all members of a peer group and represents a realistic standard of excellence attained by the top performers in that group (i.e. comparing to the top 10% of peers). Educational outreach: A trained independent person or investigator will meet with health professionals or managers in their practice setting to provide information (e.g. feedback of quality indicators). Action planning: The purpose of action planning is to support quality improvement efforts by identifying opportunities for improvement, strategies and steps to accomplish the work.

Locations

Country	Name	City	State
Belgium	Sint-Trudo Ziekenhuis	Sint-Truiden

Sponsors (2)

Lead Sponsor	Collaborator
KU Leuven	Sint-Trudo Hospital

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital mortality	In-hospital mortality rate	During admission
Primary	Patient experiences	Experiences of patients will be measures by a validated questionnaire (Flemisch Patient Experience Questionnaire).; Q: Will you recommend our hospital? (scale min 0 until 10 with 0: not and 10: for sure).; For follow questions the scores are 'disagree', 'somewhat agree', 'largely agree', 'totally agree. The higher the score the better the outcome Q: This information was provided by my GP or by healthcare providers in the hospital.; Q: I understand the information I received about the cost of my stay. Q: I received sufficient information about the causes of my condition or about the possible treatment methods for my condition or about the consequences of my disease.; Q: Nurses or doctors explained things in a way I could understand or treated me with courtesy and respect.; Q: My privacy was respected during conversations with caregivers or during examinations, treatment and care.; Q: Before any treatment my identity was checked. Q: Hospital staff always introduced themselves	During admission
Primary	In-hospital length of stay	Length of stay of each patient in the hospital	During admission
Primary	Adverse events and adverse outcomes	Each adverse event and following adverse outcomes will be measured: urinary tract infections, pressure ulcers, hospital-acquired pneumonia, shock/cardiac arrest, upper-gastrointestinal bleeding, hospital-acquired sepsis, deep venous thrombosis, central nervous system complications, surgical wound infection, pulmonary failure, metabolic derangement, methicillin-resistant Staphylococcus aureus, vancomycin resistant Enterococcus, central line associated bloodstream infections, carbapenemase producing Enterobacteriaceae	During admission
Primary	Failure to rescue rate	The failure to rescue rate for each patient admitted in the hospital will be evaluated	During admission
Primary	Readmission rate	Readmission within 30 days of each patient admitted in the hospital	30 days after discharge